To view this email as a web page, click here.
 
BIOLOGICS
 
Asthma biologic may reduce oral steroid use
Study finds that asthma patients treated with benralizumab were more likely to reduce their oral corticosteroid dose than those treated with placebo.
Read more
 
First generic Strattera for ADHD approved
FDA has approved the first generic versions of Strattera for the treatment of attention deficit/hyperactivity disorder.
Read more
 
How pharma reps impact physician prescribing
Study finds that limiting marketing by pharmaceutical sales representatives may change physician prescribing habits.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.